Investments
28Portfolio Exits
17Funds
5Service Providers
1Latest SVB Leerink News
May 24, 2022
The shares of AbbVie Inc (NYSE: ABBV) have received a $140 price target from SVB Leerink. These are the details. The shares of AbbVie Inc (NYSE: ABBV) have received a $140 price target from SVB Leerink. And SVB Leerink analyst David Risinger initiated coverage of AbbVie with an “Underperform” rating. Risinger noted that management has delivered exceptional performance, but he is projecting 2024-2025 EPS 6%-8% below consensus due to Humira biosimilar pressures accelerating in mid-2023 when several biosimilars launch and AbbVie’s business reinvestment requirements. Currently, Risinger sees the stock as a crowded defensive play and anticipates downward analyst revisions ahead for 2024-2025 EPS as AbbVie’s financial picture becomes clearer. Plus Risinger respects the management team’s execution and performance to date. Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.
SVB Leerink Investments
28 Investments
SVB Leerink has made 28 investments. Their latest investment was in Umoja Biopharma as part of their Series B on June 6, 2021.
SVB Leerink Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
6/15/2021 | Series B | Umoja Biopharma | $210M | Yes | 13 | |
12/14/2020 | Series B | LocanaBio | $100M | Yes | 28 | |
8/4/2020 | Series C | Kinnate Biopharma | $98M | Yes | 5 | |
4/6/2020 | Series E | |||||
1/10/2020 | Series C |
Date | 6/15/2021 | 12/14/2020 | 8/4/2020 | 4/6/2020 | 1/10/2020 |
|---|---|---|---|---|---|
Round | Series B | Series B | Series C | Series E | Series C |
Company | Umoja Biopharma | LocanaBio | Kinnate Biopharma | ||
Amount | $210M | $100M | $98M | ||
New? | Yes | Yes | Yes | ||
Co-Investors | |||||
Sources | 13 | 28 | 5 |
SVB Leerink Portfolio Exits
17 Portfolio Exits
SVB Leerink has 17 portfolio exits. Their latest portfolio exit was Vera Whole Health on July 01, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
7/1/2021 | Acq - Fin | 2 | |||
3/22/2021 | Acquired | 8 | |||
12/3/2020 | IPO | 11 | |||
Date | 7/1/2021 | 3/22/2021 | 12/3/2020 | ||
|---|---|---|---|---|---|
Exit | Acq - Fin | Acquired | IPO | ||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 2 | 8 | 11 |
SVB Leerink Fund History
5 Fund Histories
SVB Leerink has 5 funds, including Leerink Revelation Partners Fund II.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
6/12/2018 | Leerink Revelation Partners Fund II | $227M | 1 | ||
9/29/2017 | Health IT Growth Equity Fund I | ||||
7/6/2016 | Leerink Transformation Fund I | ||||
6/11/2015 | LEERINK Revelation Partners | ||||
Massachusetts Innovation Catalyst Fund |
Closing Date | 6/12/2018 | 9/29/2017 | 7/6/2016 | 6/11/2015 | |
|---|---|---|---|---|---|
Fund | Leerink Revelation Partners Fund II | Health IT Growth Equity Fund I | Leerink Transformation Fund I | LEERINK Revelation Partners | Massachusetts Innovation Catalyst Fund |
Fund Type | |||||
Status | |||||
Amount | $227M | ||||
Sources | 1 |
SVB Leerink Service Providers
1 Service Provider
SVB Leerink has 1 service provider relationship
Service Provider | Associated Rounds | Provider Type | Service Type |
|---|---|---|---|
Acquired | Investment Bank | Financial Advisor |
Service Provider | |
|---|---|
Associated Rounds | Acquired |
Provider Type | Investment Bank |
Service Type | Financial Advisor |
Partnership data by VentureSource
SVB Leerink Team
20 Team Members
SVB Leerink has 20 team members, including current Chief Executive Officer, Jeffrey A. Leerink.
Name | Work History | Title | Status |
|---|---|---|---|
Jeffrey A. Leerink | Chief Executive Officer | Current | |
Joseph Gentile | Chief Administrative Officer | Current | |
James Boylan | Senior Managing Director | Current | |
Doug Brown | Senior Managing Director | Current | |
Jon Civitarese | Managing Director | Current |
Name | Jeffrey A. Leerink | Joseph Gentile | James Boylan | Doug Brown | Jon Civitarese |
|---|---|---|---|---|---|
Work History | |||||
Title | Chief Executive Officer | Chief Administrative Officer | Senior Managing Director | Senior Managing Director | Managing Director |
Status | Current | Current | Current | Current | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.